glp-1 weight loss long-term Bariatric Surgery vs Medications for GLP-1 Medications Beyond Weight Loss

Four distinct areas of the lower face typically show the most noticeable changes after GLP-1-induced weight loss: Jowl formation Skin and soft tissue descend below the jawline border, disrupting the smooth jaw contour Pre-jowl sulcus Hollows develop on either side of the chin, creating a stepped appearance along the jaw Marionette lines Deep creases form from mouth corners to the chin as volume loss allows tissue descent Submental changes The area under the chin may appear loose or develop banding as platysma muscle becomes more visible What Are the Best Non-Surgical Treatments for Jawline Support in 2026

To piggyback off of that, this post is the practical toolkit

doi: 10.1007/s40262-017-0531-7 [DOI] [PubMed] [Google Scholar] 156.Morse BL, Alberts JJ, Posada MM, et al

Despite the name, they contain no GLP-1 hormones and no GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide)

Tirzepatide has been shown to decrease food intake and increase energy expenditure therefore resulting in weight reductions and weight loss programs, and due to it's unique property, may result in greater effects on body weight, glucose and lipids

Semaglutide 2.4 mg (Wegovy) has shown robust weight loss in primary obesity trials, with mean weight reductions of 14.9% in the STEP 1 trial published in the New England Journal of Medicine (2021)